Postby Achilles Torn » Thu Jun 01, 2017 2:37 pm
Hi Missy,
Sorry - I don't have experience with Zaltrap (ziv-aflibercept). From my limited knowledge, it doesn't have as wide use in second line treatment as the EGFR inhibitors Vectibix (panitumumab) and Erbitux (Cetuximab) for which many have good results. (EGFR inhibitors seem to have limited clinical benefit for certain KRAS/NRAS mutations so perhaps that is why they aren't being used)
If you haven't already you should ask about genetic testing of your husband's tumor as it can be important to making treatment decisions. In particular, if he is MSI (around 15% of Colorectal Cancer) it would indicate immunotherapy may be better than standard chemotherapy and might explain his lack of response to Chemo.
If you use the search function on the board you can probably find previous posts where Zaltrap was discussed but I would echo Lee and get a second opinion and don't be afraid to ask his oncologist as many questions as you need.
AT
Diagnosed as 40 yo Male. BC Canada. Sigmoid Colectomy Dec. 2016
Pathology T3N2bM1 19 of 24 Nodes Positive + tumour deposits
PET scan - Para-Aortic and Iliac Lymph node spread. Stage VI.
Moderately differentiated. MSS. KRAS/BRAF Wild.
Mutations: TP53, ERBB4, MLL3, PDCD1LG2, PRKDC, SMAD3
FOLFOX + Bevacizumab Commenced Jan 9/2017 PET Scan July 2017 - on maintenance 5FU/Bev every 2 weeks.
Progression after Covid19 induced break June 2020. Resume Maintenance chemo of Capecitabine and Bev